Interactive ARV Projections Tool
Since 2013, the World Health Organization (WHO) and the Medicines Patent Pool (MPP) have collaborated on antiretroviral (ARV) projections incorporating technical advice, medical inputs and data from several partners as well as information about the latest scientific advancements. In addition to being shared with stakeholders and manufacturers, WHO-MPP projections have been published in peer-reviewed journal PLoS One and are updated annually. Today, these projections are an essential tool that helps guide the work of the MPP and its industry partners while facilitating timely generic development of pipeline ARVs for distribution in low- and middle-income countries.
In an effort to make these projections more accessible and user-friendly, the MPP has developed an interactive ARV projections tool intended to assist manufacturing companies and other industry partners in the decision-making. Modelled from the joint WHO-MPP peer-reviewed projections, the tool provides active pharmaceutical ingredient (API) and regimen-wise projections for adults and children, first and second-line treatment segments.
How it works:
The two-step tool allows for users to select the preferred uptake scenario (i.e., conservative, likely use, aggressive). After which, users can choose to customise the projections by regimen (first, second, third lines) and segment (adult, paediatric) or otherwise utilise the automated output. The output can be viewed graphically or tabularly, available for download and printing. The tool is updated annually.